Zeprumetostat

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Zeprumetostat is an orally active EZH2 inhibitor. Zeprumetostat inhibits wild-type and Y641F mutant EZH2 with IC50 values of 0.87 nM and 2.68 nM, respectively. Zeprumetostat induces cell cycle arrest and apoptosis, inhibits tumor cell proliferation, reduces target protein levels, and modulates oncogenic signaling pathway genes. Zeprumetostat combined with Tucidinostat (HY-109015) enhances antitumor efficacy through STAT1 and inhibits tumor growth in xenograft models. Zeprumetostat can be used for lymphoma-related research.

For research use only. We do not sell to patients.

  • Purity : 99.18%
  • CAS No.: 2098545-98-1
  • Formula: C32H44N4O4
  • Molecular Weight:548.72
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00